Results 291 to 300 of about 208,301 (303)

A pan-KRAS inhibitor and its derived degrader elicit multifaceted anti-tumor efficacy in KRAS-driven cancers

Cancer Cell
Juanjuan Feng, Xinting Xia, zhengke lian
exaly  

Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer

Cancer Cell
xinyuan tong, Shengwu Liu, Julien Dilly
exaly  

KRAS inhibitors at last

Nature Medicine, 2020
openaire   +2 more sources

Kra

Punkt: Almanach Gdańskich Środowisk Twórczych, 1979
openaire  

Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancer

Cancer Cell
Caicun Zhou
exaly  

KRAS Gene

2020
openaire   +1 more source

A first-in-class EGFR-directed KRAS G12V selective inhibitor

Cancer Cell
Martin Egli, Katherine I Zhou, Chad V Pecot   +2 more
exaly  

Kras kritik

2022
openaire   +1 more source

KRAS Mutations

2016
openaire   +1 more source

Another KRAS variant trapped

Nature Chemical Biology
openaire   +2 more sources